UCSF Prof of Emerg Med | Founder @aliemteam | Author, Tricks of Trade in EM Building in public: An AI-native OS for academia & leadership.
California, USA
Joined April 2009
- Tweets6.1K
- Following188
- Followers19.5K
- Likes5.7K
Michelle Lin, MD retweeted
🚨 New PECARN Study Alert! 🚨
The PECARN STArT trial asked an important question: Could IV arginine help children and young adults with sickle cell disease recover faster from acute pain episodes?
jamanetwork.com/journals/jam…
#SPARC #PECARN #SickleCellDisease
Michelle Lin, MD retweeted
Intern year is coming. 👀
ALiEM's Bridge to EM is designed to make your transition from medical student to EM resident smooth. Check it out at: emra.org/aliem
#BridgeToEM #ALiEM #InternYear #EM #MedEd #EMBound
Michelle Lin, MD retweeted
🚨 New @NEJM landmark trial from @PECARNteam:
PRoMPT BOLUS randomized 9,000+ children with suspected septic shock to balanced crystalloid vs 0.9% saline. No difference in kidney injury, mortality, or safety. Either is 👍.
📄 doi.org/10.1056/NEJMoa260196…
🩺 aliem.com/prompt-bolus-pedia…
Michelle Lin, MD retweeted
🫀 New AIR module: Non-ACS Cardiology (2026)
✅ 5 hrs of conference credit
9 curated posts on SVT, RV failure, SCAPE, valvular disease & more.
🔗 aliem.com/air-series-non-acs…
Series Editor: Kaitlin Bowers, DO @kbowersdo
Sponsors: @SAEM_Online + @CORD_EM
140 unfilled EM spots in 2026 — should we be worried? 🤔
Drs. @SMKrzyz & @DrAbracadabra unpack the match numbers, the Residency CAS effect, and what it means for the future of EM recruitment 🎙️
aliem.com/em-match-advice-51…
@CORD_EM
Michelle Lin, MD retweeted
"The jury is still out for treatment with arginine therapy." — Dr. @claudiarmorris1
The #PECARN STArT trial — a double-blind RCT testing IV arginine for sickle cell pain crises in children and young adults — was stopped early after an interim analysis suggested the primary endpoint was unlikely to be met.
But Dr. Morris isn't ready to close the book on the drug. Here's why 👇 🔗 hcplive.com/view/pecarn-star…
#SPARC #PECARN #PediatricEmergencyMedicine #EmergencyMedicine #SickleCell
Michelle Lin, MD retweeted
#NewBlogPost
Most sepsis screening tools identify kids who already have sepsis, or who are already suspected of infection. That's useful — but it's not early enough.
This @PECARN model predicts who will develop sepsis in the next 48 hours, across the general ED population, before clinical suspicion even forms.
Earlier signal ➡️ earlier intervention ➡️ better outcomes. The biology hasn't changed. The tooling has.
@JBelferMD @ERAlpernMD @FranBalamuth
pecarn.org/pecarn_news/one-s…
#PRIME #PEMNEWS #PediatricEmergencyMedicine #Pediatric #EmergencyMedicine #SEPSIS
Michelle Lin, MD retweeted
Same disease. Same pain crisis. Same type of hospital. One child goes home in 28 hours. Another stays nearly 6 days.
A new secondary analysis from the #PECARN STArT trial — the largest pediatric sickle cell pain crisis trial enrollment to date — found that *where* a child receives care may matter as much as *how sick they are*.
The findings are worth a close read.
🔗 pecarn.org/pecarn_news/same-…
#SPARC #PediatricEmergencyMedicine #Pediatric #SickleCell
Michelle Lin, MD retweeted
🚨New #PECARN Blog Post 🚨
Check out the latest blog, "The End of Routine Lumbar Punctures for the Febrile Infant 28 Days and Younger"
@M_Lin walks through a recent #PECARN study to share the changing landscape of lumbar punctures for young infants
Read it here 👉🏼 pecarn.org/pecarn_news/the-e…
#PRIME #EmergencyMedicine #Pediatrics #FebrileInfant
@JAMA_current
Michelle Lin, MD retweeted
After 8 years, 240 faculty, and countless Slack conversations, we're closing a chapter—and celebrating a legacy. 🎉
📚The Education Theory Made Practical book series is complete: 8 volumes, 77 theories, all FREE.
Here's to what we built together.
aliem.com/education-theory-m…
... I wrote about it — and I'm now building in public. Follow along to see what happens when a non-coder stops waiting for permission.
For years I had more ideas than I could build. No coding skills, no collaborators available at 2am after night shifts.
That was the ceiling. Then I started using AI as a building partner.
The ceiling is gone. 🔓
I wrote about it — and I'm now buildi...
michellelinmd.com/blog/the-c…
I spent 10 years frustrated with Google Analytics, never once asking: "Is there another way?" 🤔
Switched to self-hosted Umami. Clean dashboard. My data. No ad blockers stealing accuracy.
The aha moment wasn't finding the alternative—it was learning ...
michellelinmd.com/blog/googl…
For years I built one-off, simple, no-code tools that worked but at a cost— jerry-rigged spreadsheets, screenshot-filled instruction manuals, workarounds I'd forget in 3 months.
The missing piece wasn't another app.
It was memory. 🧠
michellelinmd.com/blog/2026-…
